Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Curent Deferred Tax Liability: 2013-2015

Historic Curent Deferred Tax Liability for Cross Country Healthcare (CCRN) over the last 3 years, with Q3 2015 value amounting to $2.0 million.

  • Cross Country Healthcare's Curent Deferred Tax Liability rose 21959.25% to $2.0 million in Q3 2015 from the same period last year, while for Sep 2015 it was $2.0 million, marking a year-over-year increase of 21959.25%. This contributed to the annual value of $2.0 million for FY2014, which is 27028.04% up from last year.
  • Cross Country Healthcare's Curent Deferred Tax Liability amounted to $2.0 million in Q3 2015, which was up 21959.25% from $1.7 million recorded in Q2 2015.
  • Cross Country Healthcare's Curent Deferred Tax Liability's 5-year high stood at $2.0 million during Q3 2015, with a 5-year trough of $535000.0 in Q4 2013.
  • Moreover, its 3-year median value for Curent Deferred Tax Liability was $1.2 million (2014), whereas its average is $1.2 million.
  • Per our database at Business Quant, Cross Country Healthcare's Curent Deferred Tax Liability skyrocketed by 27028.04% in 2014 and then surged by 17974.28% in 2015.
  • Cross Country Healthcare's Curent Deferred Tax Liability (Quarter) stood at $535000.0 in 2013, then surged by 270.28% to $2.0 million in 2014, then grew by 2.93% to $2.0 million in 2015.
  • Its last three reported values are $2.0 million in Q3 2015, $1.7 million for Q2 2015, and $1.7 million during Q1 2015.